EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The diversity of clinical Mycobacterium abscessus isolates in morphology, glycopeptidolipids and infection rates in a macrophage model

Virginia Pichler, Lara Dalkilic, Ghazaleh Shoaib, Tirosh Shapira, Leah Rankine-Wilson, Yves-Marie Boudehen, Joseph D Chao, Danielle Sexton, Miguel Prieto, Bradley S Quon, Elitza I Tocheva, Laurent Kremer und 2 weitere

Journal of Medical Microbiology · 2024

DOI: 10.1099/jmm.0.001869 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2024. Verfasst von Virginia Pichler und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, Canada. Hauptthemen laut MEDLINE: Mycobacterium abscessus, Macrophages, Mycobacterium Infections, Nontuberculous, Glycolipids. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of British Columbia, Cystic Fibrosis Canada, Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Mycobacterium abscessus (MABS) is a pathogenic bacterium that can cause severe lung infections, particularly in individuals with cystic fibrosis. MABS colonies can exhibit either a smooth (S) or rough (R) morphotype, influenced by the presence or absence of glycopeptidolipids (GPLs) on their surface, respectively. Despite the clinical significance of these morphotypes, the relationship between GPL levels, morphotype and the pathogenesis of MABS infections remains poorly understood. Gap statement. The mechanisms and implications of GPL production and morphotypes in clinical MABS infections are unclear. There is a gap in understanding their correlation with infectivity and pathogenicity, particularly in patients with underlying lung disease.

Aim

This study aimed to investigate the correlation between MABS morphology, GPL and infectivity by analysing strains from cystic fibrosis patients’ sputum samples. Methodology. MABS was isolated from patient sputum samples and categorized by morphotype, GPL profile and replication rate in macrophages. A high-content ex vivo infection model using THP-1 cells assessed the infectivity of both clinical and laboratory strains.

Results

Our findings revealed that around 50 % of isolates displayed mixed morphologies. GPL analysis confirmed a consistent relationship between GPL content and morphotype that was only found in smooth isolates. Across morphotype groups, no differences were observed in vitro , yet clinical R strains were observed to replicate at higher levels in the THP-1 infection model. Moreover, the proportion of infected macrophages was notably higher among clinical R strains compared to their S counterparts at 72 h post-infection. Clinical variants also infected THP-1 cells at significantly higher rates compared to laboratory strains, highlighting the limited translatability of lab strain infection data to clinical contexts.

Conclusion

Our study confirmed the general correlation between morphotype and GPL levels in smooth strains yet unveiled more variability within morphotype groups than previously recognized, particularly during intracellular infection. As the R morphotype is the highest clinical concern, these findings contribute to the expanding knowledge base surrounding MABS infections, offering insights that can steer diagnostic methodologies and treatment approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium abscessusMacrophagesMycobacterium Infections, NontuberculousGlycolipidsHumansTHP-1 CellsCystic FibrosisSputumGlycopeptides

Stichwörter der Autor:innen

MycobacteriaMycobacterium abscessusbacterial disseminationclinical infectioncolony morphologycystic fibrosisglycopeptidolipidshost-pathogen interactionintracellular pathogensmacrophage modelpathogenesis

Substanzen

GlycolipidsGlycopeptides

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, Canada.
  • INSERM, IRIM, 34293 Montpellier, France.
  • Department of Medicine, University of British Columbia, Vancouver, Canada.
  • Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada.

Förderung

  • University of British Columbia
  • Cystic Fibrosis Canada
  • Agence Nationale de la Recherche

Zitieren

APA

Pichler, V., Dalkilic, L., Shoaib, G., Shapira, T., Rankine-Wilson, L., Boudehen, Y. M., Chao, J. D., Sexton, D., Prieto, M., Quon, B. S., Tocheva, E. I., Kremer, L., Hsiao, W., & Av-Gay, Y. (2024). The diversity of clinical Mycobacterium abscessus isolates in morphology, glycopeptidolipids and infection rates in a macrophage model. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.001869

Vancouver

Pichler V, Dalkilic L, Shoaib G, Shapira T, Rankine-Wilson L, Boudehen YM, et al. The diversity of clinical Mycobacterium abscessus isolates in morphology, glycopeptidolipids and infection rates in a macrophage model. Journal of Medical Microbiology. 2024. doi:10.1099/jmm.0.001869

BibTeX
@article{Pichler2024,
  author = {Pichler, Virginia and Dalkilic, Lara and Shoaib, Ghazaleh and Shapira, Tirosh and Rankine-Wilson, Leah and Boudehen, Yves-Marie and Chao, Joseph D and Sexton, Danielle and Prieto, Miguel and Quon, Bradley S and Tocheva, Elitza I and Kremer, Laurent and Hsiao, William and Av-Gay, Yossef},
  title = {The diversity of clinical Mycobacterium abscessus isolates in morphology, glycopeptidolipids and infection rates in a macrophage model},
  journal = {Journal of Medical Microbiology},
  year = {2024},
  doi = {10.1099/jmm.0.001869}
}
Kostenlos starten →